Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2014-06-26

Clinical Trial Update: Persistent Atrial Fibrillation Ablation Trial [NA]

View source ↗

Summary

A clinical trial (NCT01891825) evaluating persistent atrial fibrillation ablation is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neil Sulke | Conditions: Atrial Fibrillation | NA | Status: SUSPENDED